Skip to NavigationSkip to content


Government spend £9.2 billion on private healthcare providers for NHS in 2018-19

The Department of Health and Social Care paid £9.2 billion to private providers in the year prior to 31 March 2019, according to their annual report.

The 14% increase comes as health secretary Matt Hancock pledged to reduce the outsourcing of patient care. “There is no privatisation of the NHS on my watch,” Hancock said to MPs and health chiefs in January 2019.

Trump says executive order will ensure US will pay lowest prices in the world for drugs

President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United States pays the same price for pharmaceutical drugs as those countries that pay the lowest prices in the world.  

UK Government call for more research into medicinal cannabis

The British government has called for more research into cannabis-based medicinal products (CBMPs).

In a paper published on 3 July, the government said: “The research and evidence gap needs to be addressed to determine whether and if so which patients could benefit from CBPMs, and their place in treatment options.”

Donald Trump says he will not accept campaign money from pharma

President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 elections.

Speaking at the Rx Heroin and Drug Abuse Summit in Atlanta, Trump said the industry “should be held accountable” for the role they played in the opioid crisis as he declared that he would not accept campaign contributions from pharma.

“My administration is also taking aggressive action to reduce the oversupply of highly addictive prescription drugs,” Trump said.

Government appoints health minister from firm trying to win NHS contracts

The British Government has come under fire over the appointment of former Tory MP, Nicola Blackwood, as a junior minister in the Department of Health and Social Care, after it was revealed that she had previously sat on the governance board of a company hoping to be contracted by the NHS.

NHS overcrowding leads to ambulances being turned away

NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above 85% is unsafe.

Meanwhile ambulances have been turned away, as overcrowded hospitals have put patients at risk.

The overcrowding has led to eight ambulances being turned away from A&Es, while significant numbers of ambulances were facing serious delays.

While ambulances should be able to drop patients off within 15 minutes of arrival, in one in nine cases it took more than twice as long.

Top Ten most popular articles on this week!

The appointment of GSK veteran Arnaud Breabout to the position of Senior Vice President and CFO of Mundipharma took the top spot this week. Meanwhile MHRA chief Dr Ian Hudson announced he was stepping down.

Equally as Brexit inched ever closer it was revealed that use of antidepressant had gone up in the month following the referendum. At the same time, the ABPI responded to Theresa May’s new deal.

Pfizer ask Senator Cindy Hyde-Smith to refund campaign donation after 'public hanging' comments

American pharma giant Pfizer have asked Mississippi Republican Senator Cindy Hyde-Smith to return campaign donations after the candidate was filmed joking about attending a “public hanging”.

Hyde-Smith said in a video that appeared on social media, “If he invited me to a public hanging, I'd be on the front row.”  Pfizer made two donations towards Hyde-Smith’s campaign, coming to a total of $5000.

Top Ten most popular articles on this week!

The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from the South Korean stock exchange over accounting violations. Equally Brexit chaos was central to this weeks’ news after a deal was revealed by Theresa May. The ongoing disruption has seen the resignation of a number of prominent players as backbench Brexiteer Jacob Rees Mogg called for a vote of no-confidence in Theresa May.

Phamaceutical trade lobby responds to Brexit deal

The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a 585 page draft withdrawal agreement has been agreed to by both the United Kingdom and the European Union.

However both the British and EU parliaments will now have to ratify the agreement. The news has already led to the resignation of Brexit Secretary Dominic Raab and Secretary of State for work and pensions, Esther McVey.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches